Q32 Bio (QTTB) Operating Income (2018 - 2025)
Historic Operating Income for Q32 Bio (QTTB) over the last 8 years, with Q3 2025 value amounting to -$7.6 million.
- Q32 Bio's Operating Income rose 5972.68% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$43.5 million, marking a year-over-year increase of 4378.5%. This contributed to the annual value of -$66.1 million for FY2024, which is 3698.48% down from last year.
- Per Q32 Bio's latest filing, its Operating Income stood at -$7.6 million for Q3 2025, which was up 5972.68% from -$9.2 million recorded in Q2 2025.
- Q32 Bio's 5-year Operating Income high stood at -$1.1 million for Q1 2021, and its period low was -$37.6 million during Q1 2022.
- Over the past 5 years, Q32 Bio's median Operating Income value was -$17.9 million (recorded in 2024), while the average stood at -$19.6 million.
- As far as peak fluctuations go, Q32 Bio's Operating Income surged by 9695.55% in 2021, and later tumbled by 328595.86% in 2022.
- Over the past 5 years, Q32 Bio's Operating Income (Quarter) stood at -$33.6 million in 2021, then decreased by 2.58% to -$34.5 million in 2022, then increased by 25.18% to -$25.8 million in 2023, then skyrocketed by 43.72% to -$14.5 million in 2024, then surged by 47.84% to -$7.6 million in 2025.
- Its Operating Income was -$7.6 million in Q3 2025, compared to -$9.2 million in Q2 2025 and -$12.2 million in Q1 2025.